FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: TESTOSTERONE USE IN MENOPAUSAL WOMEN; PUBLIC WORKSHOP; REQUEST FOR COMMENTS

WASHINGTON, Aug. 18 -- Food and Drug Administration has issued a notice called: Testosterone Use in Menopausal Women; Public Workshop; Request for Comments.

The notice was published in the Federal Register on Aug. 18 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration's (FDA) Office of Women's Health and the Center for Drug Evaluation and Research are announcing a public workshop titled "Testosterone Use in Menopausal Women." The purpose of the public workshop is to examine the current scientific evidence and critical knowledge gaps related to testosterone use in menopausal women to help inform future research and potential drug development of testosterone p...